Dulabh Monga

1.4k total citations
74 papers, 1.1k citations indexed

About

Dulabh Monga is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dulabh Monga has authored 74 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 22 papers in Surgery and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dulabh Monga's work include Pancreatic and Hepatic Oncology Research (17 papers), Colorectal Cancer Surgical Treatments (14 papers) and Colorectal and Anal Carcinomas (13 papers). Dulabh Monga is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Colorectal Cancer Surgical Treatments (14 papers) and Colorectal and Anal Carcinomas (13 papers). Dulabh Monga collaborates with scholars based in United States, India and Germany. Dulabh Monga's co-authors include Satdarshan P. Monga, Amanda Micsenyi, Rodney E. Wegner, Aaron Bell, Xinping Tan, Gene Grant Finley, Alexander V. Kirichenko, Shaakir Hasan, Moses S. Raj and Michael J. O’Connell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Dulabh Monga

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dulabh Monga United States 15 539 396 277 227 158 74 1.1k
Xinyu Bi China 17 480 0.9× 361 0.9× 316 1.1× 289 1.3× 400 2.5× 100 1.2k
Bum Jun Kim South Korea 18 536 1.0× 337 0.9× 294 1.1× 449 2.0× 277 1.8× 60 1.1k
Diana L. Hanna United States 17 600 1.1× 238 0.6× 164 0.6× 250 1.1× 117 0.7× 75 1.0k
Koji Miyahara Japan 17 309 0.6× 275 0.7× 171 0.6× 184 0.8× 276 1.7× 45 906
Kohei Shigeta Japan 15 590 1.1× 139 0.4× 260 0.9× 210 0.9× 134 0.8× 75 945
Hisafumi Kinoshita Japan 19 621 1.2× 561 1.4× 545 2.0× 385 1.7× 249 1.6× 94 1.5k
Ingrid Garajová Italy 19 503 0.9× 404 1.0× 203 0.7× 218 1.0× 154 1.0× 82 1.0k
Susanna V. Ulahannan United States 17 524 1.0× 324 0.8× 106 0.4× 192 0.8× 217 1.4× 89 1.1k
Xiaochu Yan China 13 289 0.5× 254 0.6× 184 0.7× 136 0.6× 214 1.4× 33 801
Masayuki Otsuka Japan 15 300 0.6× 343 0.9× 227 0.8× 121 0.5× 122 0.8× 73 847

Countries citing papers authored by Dulabh Monga

Since Specialization
Citations

This map shows the geographic impact of Dulabh Monga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dulabh Monga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dulabh Monga more than expected).

Fields of papers citing papers by Dulabh Monga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dulabh Monga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dulabh Monga. The network helps show where Dulabh Monga may publish in the future.

Co-authorship network of co-authors of Dulabh Monga

This figure shows the co-authorship network connecting the top 25 collaborators of Dulabh Monga. A scholar is included among the top collaborators of Dulabh Monga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dulabh Monga. Dulabh Monga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iqbal, Sabah, et al.. (2024). Long-term clinical outcomes of [177Lu]Lu-DOTATATE in patients with metastatic neuroendocrine tumors. Frontiers in Oncology. 14. 1393317–1393317. 1 indexed citations
2.
Monga, Dulabh, et al.. (2023). Targeted Therapy for BRAF V600E Positive Pancreatic Adenocarcinoma: Two Case Reports. Cancer Genomics & Proteomics. 20(4). 398–403. 4 indexed citations
3.
Wegner, Rodney E., et al.. (2023). Racial and socioeconomic disparities in time to chemotherapy and survival in patients with pancreatic cancer.. Journal of Clinical Oncology. 41(16_suppl). 4100–4100.
5.
Raj, Moses S., et al.. (2022). Rechallenging Fluoropyrimidine-Induced Cardiotoxicity and Neurotoxicity: A Report of Two Cases. Cureus. 14(7). e26824–e26824. 1 indexed citations
7.
Shankar, Karthik, et al.. (2021). An Internal Review of Rates of Palliative Medicine Referral for Patients With Advanced Pancreatic Cancer. Cureus. 13(11). e19670–e19670. 1 indexed citations
8.
Jayakrishnan, Thejus, Dulabh Monga, Gene Grant Finley, et al.. (2021). Chemotherapy use in early stage anal canal squamous cell carcinoma and its impact on long-term overall survival,,,. Cancer Treatment and Research Communications. 27. 100347–100347. 2 indexed citations
9.
Shah, Deep, et al.. (2020). A Rare Case of Locally Advanced Primary Small Cell Neuroendocrine Carcinoma of the Adrenal Gland. Anticancer Research. 40(10). 5933–5938. 2 indexed citations
10.
Jayakrishnan, Thejus, et al.. (2020). Abstract PO-206: Influence of social determinants of health on timeliness to treatment for metastatic HCC and the impact of Affordable Care Act. Cancer Epidemiology Biomarkers & Prevention. 29(12_Supplement). PO–206.
11.
Khattab, Ahmed & Dulabh Monga. (2019). Cancer, Male Breast Cancer. StatPearls. 2 indexed citations
12.
Wegner, Rodney E., Stephen Abel, Shaakir Hasan, et al.. (2019). Time from Stereotactic Radiotherapy to Immunotherapy Is a Predictor for Outcome in Stage IV Non-Small Cell Lung Cancer. 3(2). 6–13. 6 indexed citations
13.
Abel, Stephen, Gene Grant Finley, Moses S. Raj, et al.. (2019). Retrospective review of total neoadjuvant therapy. World Journal of Gastrointestinal Oncology. 11(10). 857–865. 5 indexed citations
14.
Syed, Aslam, Neil Carleton, Zachary D. Horne, et al.. (2019). Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy. Journal of Gastrointestinal Cancer. 51(3). 836–843. 7 indexed citations
15.
Monga, Dulabh, et al.. (2017). Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review. Clinical Therapeutics. 39(11). 2146–2157. 13 indexed citations
16.
Singh, Shailendra, Alexander V. Kirichenko, Abhijit Kulkarni, et al.. (2017). Surgical Outcomes in Patients with Borderline Resectable Pancreatic Adenocarcinoma After Neoadjuvant Chemotherapy and Fiducial Targeted IGRT: An Institutional Experience. Gastroenterology. 152(5). S276–S277. 2 indexed citations
17.
Monga, Dulabh, et al.. (2013). An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis.. PubMed. 6(3). 90–2. 24 indexed citations
18.
Stock, Peggy, Dulabh Monga, Amanda Micsenyi, et al.. (2007). PDGFRalpha is an oncofetal target in human hepatocellular cancer. The FASEB Journal. 21(6). 1 indexed citations
19.
Monga, Dulabh & Michael J. O’Connell. (2006). Surgical Adjuvant Therapy for Colorectal Cancer: Current Approaches and Future Directions. Annals of Surgical Oncology. 13(8). 1021–1034. 46 indexed citations
20.
Tan, Xinping, Udayan Apte, Amanda Micsenyi, et al.. (2005). Epidermal Growth Factor Receptor: A Novel Target of the Wnt/β-Catenin Pathway in Liver. Gastroenterology. 129(1). 285–302. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026